Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovesudil in Normal Tension Glaucoma
NCT03106532Phase 2Completed
- Sponsor
- pH Pharma Co., Ltd.
- Start
- Mar 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AMA0076 in normal tension glaucoma (NTG), sponsored by pH Pharma Co., Ltd.. Started Mar 2017; status: completed.
02
Drugs
AMA0076
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT03106532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106532.